Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Vaccinations01:51

Vaccinations

44.8K
Overview
44.8K
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

3.3K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.3K
Development of Immunocompetence01:22

Development of Immunocompetence

357
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
357
International Nursing Organizations II01:28

International Nursing Organizations II

1.0K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.0K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

984
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
984
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

62
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
62

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Circulating Tumor Cells and Clinical Outcomes in Men with Metastatic Castration-sensitive Prostate Cancer Treated with Enzalutamide and Docetaxel: An Analysis of the ENZADA Trial.

European urology open science·2025
Same author

Using solution-phase NMR spectroscopy to study the folding and supramolecular assembly of conformationally constrained β-sheet peptides.

Methods in enzymology·2025
Same author

Mini-αA-crystallin protects a client lens protein from catastrophic aggregation due to heat stress.

Protein science : a publication of the Protein Society·2025
Same author

A β-hairpin peptide derived from Aβ forms different oligomers in the crystal state and in aqueous solution.

Organic & biomolecular chemistry·2025
Same author

Optimal human papillomavirus vaccination strategies in the context of vaccine supply constraints in 100 countries.

EClinicalMedicine·2024
Same author

The Problem with Delaying Measles Elimination.

Vaccines·2024

相关实验视频

Updated: Jul 23, 2025

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.2K

在中等收入国家加速免疫进展的机会.

Jason Zhu1, Clarke B Cole1, Johanna Fihman2

  • 1Clinton Health Access Initiative, Boston, MA, USA.

Vaccine
|July 17, 2023
PubMed
概括

中等收入国家面临疫苗接种挑战,COVID-19加剧了这一挑战. 提高免疫覆盖率可以挽救数千人的生命,需要为这些国家提供协调的全球和区域支持.

关键词:
这是科瓦克斯 (COVAX) 的产品.在 COVID-19 疫情中,覆盖范围 覆盖范围 覆盖范围盖维·加维 (Gavi Gavi) 是一个著名的艺术家.全球政策 全球政策IA203030年 IA2030年 IA2030年 IA2030年免疫接种 免疫接种中等收入国家 中等收入国家引入新的疫苗引入新疫苗联合国儿童基金会 联合国儿童基金会疫苗接种 疫苗接种世界卫生组织WHOWHO

更多相关视频

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.8K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.7K

相关实验视频

Last Updated: Jul 23, 2025

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.2K
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
23:56

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model

Published on: October 31, 2010

16.8K
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.7K

科学领域:

  • 全球健康 全球健康
  • 免疫接种计划 免疫接种计划
  • 疫苗接种权限 疫苗接种权限

背景情况:

  • 中等收入国家 (MICs) 面临着重大疫苗接种挑战,特别是那些无法获得或从Gavi转型的国家,疫苗联盟支持.
  • 随着COVID-19的流行,MICs的免疫计划的现有困难加剧了,可能导致疫苗推迟推出,覆盖率下降和不平等增加.
  • 改善MICs的免疫结果提供了大量潜在的健康和公平利益.

研究的目的:

  • 确定可行的策略,以加快中等收入国家的免疫进展.
  • 利用新的全球平台和区域机制,为MICs提供协调支持.
  • 解决疫苗接种挑战,改善Gavi转型和非Gavi资格国家的免疫覆盖率.

主要方法:

  • 分析中等收入国家的疫苗接种挑战.
  • 模拟新疫苗引入和覆盖率增加的影响.
  • 开展全面的多方利益相关者商,以确定需要采取行动的关键领域.

主要成果:

  • 到2020年,在MIC中引入肺炎球菌,轮状病毒和HPV疫苗,可以在90%的覆盖率下挽救大约7万人的生命.
  • 将现有疫苗的覆盖率提高到90%,可能会挽救另外16000人的生命.
  • 现有的努力和新的全球平台 (Gavi 5.0,疫苗接种议程2030) 为协调战略和支持提供了机会.

结论:

  • 协调全球和区域努力对于解决中等收入国家免疫障碍至关重要.
  • 通过多方利益相关者商确定了可行的战略,必须实施,适应国家特定的环境.
  • 利用全球平台和流行病应对机会可以加强对MICs的长期免疫支持.